Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Treatment Strategy
100%
Non-HIV Cryptococcal Meningitis
100%
Flucytosine
60%
Fluconazole
60%
Confidence Interval
60%
Liposomal Amphotericin B
60%
Induction Therapy
40%
Randomized Clinical Trial
40%
Adverse Events
40%
Control Arm
20%
First Episode
20%
People Living with HIV (PLHIV)
20%
Standard of Care
20%
Amphotericin B
20%
MEDLINE
20%
Embase
20%
Cochrane Library
20%
Inclusion Criteria
20%
PubMed
20%
Induction Treatment
20%
Deoxycholate
20%
Intention-to-treat Analysis
20%
Absolute Difference
20%
Noninferiority Margin
20%
WHO Guidelines
20%
Single High Dose
20%
Nursing and Health Professions
Systematic Review
100%
Human Immunodeficiency Virus
100%
Cryptococcal Meningitis
100%
Confidence Interval
60%
Amphotericin
60%
Fluconazole
60%
Flucytosine
60%
Medline
40%
Single Drug Dose
40%
Adverse Event
40%
World Health Organization
40%
Practice Guideline
20%
Health Care Quality
20%
Intention to Treat Analysis
20%
Cochrane Library
20%
Drug Megadose
20%
Deoxycholic Acid
20%
Amphotericin B
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Cryptococcal Meningitis
100%
Amphotericin
60%
Flucytosine
60%
Fluconazole
60%
Randomized Clinical Trial
40%
Adverse Event
40%
Deoxycholic Acid
20%
Amphotericin B
20%
Neuroscience
Human Immunodeficiency Virus
100%
Meningitis
100%
Systematic Review
100%
Fluconazole
60%
Flucytosine
60%
Amphotericin B
20%
Deoxycholic Acid
20%